Utah Medical Products | UTMD - Ebitda

Stock Price
70.65
Daily Change
1.10 1.58%
Monthly
9.71%
Yearly
34.57%
Q2 Forecast
69.10

Utah Medical Products reported $6.19M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
AngioDynamics USD 5.94M 3.78M Sep/2025
Baxter International USD 426M 36M Sep/2025
CONMED USD 80.36M 49.87M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Teleflex USD -328.81M 536.43M Sep/2025
West Pharmaceutical Services USD 218.5M 5.4M Dec/2025